We are live on ! Find out more
CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

12 hedge funds and large institutions have $412K invested in COSCIENS Biopharma Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 12 → 12 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

83% less capital invested

Capital invested by funds: $2.44M → $412K (-$2.03M)

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AG
Aperio Group
California
+$77.4K
2
TRCT
Tower Research Capital (TRC)
New York
+$38.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$25.8K
4
Citigroup
Citigroup
New York
+$12.9K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.11M
2
Deutsche Bank
Deutsche Bank
Germany
-$619K
3
BIT
BlackRock Institutional Trust
California
-$64.5K
4
VKH
Virtu KCG Holdings
New York
-$51.6K
5
Jane Street
Jane Street
New York
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
1
Aperio Group
California
$72K +$77.4K +6 New
BIT
2
BlackRock Institutional Trust
California
$57K -$64.5K -5 -50%
Renaissance Technologies
3
Renaissance Technologies
New York
$52K -$1.11M -86 -96%
TRCT
4
Tower Research Capital (TRC)
New York
$50K +$38.7K +3 +300%
CS
5
Credit Suisse
Switzerland
$41K -$12.9K -1 -25%
VKH
6
Virtu KCG Holdings
New York
$34K -$51.6K -4 -57%
Morgan Stanley
7
Morgan Stanley
New York
$33K – – –
Fifth Third Bancorp
8
Fifth Third Bancorp
Ohio
$19K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$18K +$25.8K +2 New
Cambridge Investment Research Advisors
10
Cambridge Investment Research Advisors
Iowa
$12K – – –
Citigroup
11
Citigroup
New York
$8K +$12.9K +1 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$6K – – –
Bank of Montreal
13
Bank of Montreal
Ontario, Canada
$5K – – –
MFS
14
MSI Financial Services
Massachusetts
$4K – – –
AllianceBernstein
15
AllianceBernstein
Tennessee
$1K – – –
Deutsche Bank
16
Deutsche Bank
Germany
– -$619K -48 Closed
Jane Street
17
Jane Street
New York
– -$19K -1 Closed
Two Sigma Investments
18
Two Sigma Investments
New York
– -$16K -1 Closed
Invesco
19
Invesco
Georgia
– -$2K – –

CSCI Hedge Fund Activity: Q1 2014 in Review

12 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q1 2014, worth a combined $412K — down 83% from $2.44M a quarter earlier.

Fund positioning in CSCI was balanced in Q1 2014: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 4 trimmed.

The largest buyer was Aperio Group, opening a new position worth an estimated $77.4K. The largest seller was Renaissance Technologies, cutting an estimated $1.11M.

  • 12 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $412K of COSCIENS Biopharma Inc. Common Stock stock for Q1 2014, down 83% quarter-over-quarter.
  • 3 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q1 2014 and 3 closed out, a net change of 0 holders.
  • The largest COSCIENS Biopharma Inc. Common Stock buyer in Q1 2014 was Aperio Group, an estimated $77.4K added.
  • The largest COSCIENS Biopharma Inc. Common Stock seller in Q1 2014 was Renaissance Technologies, an estimated $1.11M sold.

Based on aggregated 13F filings for Q1 2014.